Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > Evonik to merge chemical services division in Marl and Wesseling
    Finance

    Evonik to merge chemical services division in Marl and Wesseling

    Published by Global Banking & Finance Review®

    Posted on August 28, 2025

    2 min read

    Last updated: January 22, 2026

    Evonik to merge chemical services division in Marl and Wesseling - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:innovationcorporate strategyfinancial managementsustainability

    Quick Summary

    Evonik Industries will merge its Marl and Wesseling sites into Syneqt GmbH as part of restructuring, starting January 1.

    Evonik Industries to Consolidate Marl and Wesseling Chemical Sites

    (Reuters) -German chemicals group Evonik Industries said on Thursday it would merge its sites in Marl and Wesseling into a single unit as a part of the company's restructuring measures.

    The new company, Syneqt GmbH, is scheduled to begin operations on January 1 as Evonik's wholly-owned subsidiary.

    It could be incorporated into a joint venture or sold in the future, said Thomas Wessel, the company's chief human resources executive and labour relations director.

    Options under consideration range from financial investors to strategic partnerships to infrastructure service providers, Wessel added.

    Evonik's service units at the Marl and Wesseling sites employ 3,500 staff, generating around 1.8 billion euros ($2.11 billion) of annual sales.

    The new company will offer services related to chemical plants, such as energy supply and pipeline construction, as well as operation, logistics and plant security.

    Germany's chemical sector, the country's third-largest industry, continues to struggle with weak demand, a sluggish economy and, more recently, higher U.S. import tariffs.

    Aiming to slim down its business, Evonik has been undergoing the largest restructuring programme in its history, which might reduce its workforce by more than a fifth.

    ($1 = 0.8542 euros)

    (Reporting by Matthias Inverardi; writing by Anastasiia Kozlova; editing by Rachel More)

    Key Takeaways

    • •Evonik Industries to merge Marl and Wesseling sites.
    • •New company Syneqt GmbH to start operations on January 1.
    • •Potential future joint venture or sale of Syneqt GmbH.
    • •German chemical sector faces economic challenges.
    • •Evonik's restructuring may cut workforce by over 20%.

    Frequently Asked Questions about Evonik to merge chemical services division in Marl and Wesseling

    1What is the name of the new company formed by Evonik?

    The new company is called Syneqt GmbH and is set to begin operations on January 1.

    2How many employees are affected by the merger?

    The service units at the Marl and Wesseling sites employ 3,500 staff.

    3What services will Syneqt GmbH provide?

    Syneqt GmbH will offer services related to chemical plants, including energy supply, pipeline construction, operation, logistics, and plant security.

    4What challenges is Germany's chemical sector currently facing?

    Germany's chemical sector is struggling with weak demand, a sluggish economy, and higher U.S. import tariffs.

    5What restructuring measures is Evonik implementing?

    Evonik is undergoing the largest restructuring program in its history, which may reduce its workforce by more than a fifth.

    More from Finance

    Explore more articles in the Finance category

    Image for French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    French miner Eramet's finance chief steps aside temporarily, days after CEO ouster
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive
    Image for Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Belgium's Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    EU hikes tariffs on Chinese ceramics to 79% to counter dumping 
    Image for AI trade splinters as investors get more selective
    AI trade splinters as investors get more selective
    Image for EU extends tariff suspension on $109.8 billion of US imports for six months
    EU extends tariff suspension on $109.8 billion of US imports for six months
    Image for Dog food maker Ollie acquired by Spain’s Agrolimen
    Dog food maker Ollie acquired by Spain’s Agrolimen
    Image for Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    Salzgitter to take over HKM steel joint venture, end clash with Thyssenkrupp
    View All Finance Posts
    Previous Finance PostInternational coalition calls out three Chinese companies over hacking campaign
    Next Finance PostApple says UK mobile market shake-up could harm users and developers